Reports for SANDOZ RIVASTIGMINE
Brand name
SANDOZ RIVASTIGMINE
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02324563 |
Ingredients
RIVASTIGMINE |
Ingredient Strength
1.5 MG |
ATC Code
N06DA |
ATC Descriptor
ANTI-DEMENTIA DRUGS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 56 | Resolved | 2017-03-21 | 2017-05-17 | 3878 |
| SANDOZ RIVASTIGMINE | 100HGC | Resolved | 2023-03-06 | 2023-04-05 | 186300 |
| SANDOZ RIVASTIGMINE | 56 HGC | Resolved | 2023-03-27 | 2023-04-05 | 188070 |
| SANDOZ RIVASTIGMINE | 56HGC | Resolved | 2024-06-17 | 2024-12-11 | 230768 |
| SANDOZ RIVASTIGMINE | 100HGC | Resolved | 2024-08-12 | 2024-12-11 | 235071 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 100HGC BO | Discontinued | 2024-12-10 | 2024-12-11 | 245285 |
| SANDOZ RIVASTIGMINE | 56HGC | Discontinued | 2024-12-10 | 2024-12-11 | 245288 |
Showing 1 to 2 of 2